EHJ Dialogue on the year 2022 in cardiovascular medicine

(1:16:26)

EHJ Dialogue on Factor XI Inhibition in Atrial Fibrillation

(1:6:1econd)

EHJ Dialogue with Prof. Carlo Patrono on the past, present, and future of aspirin

(1:28)

EHJ Dialogue on SGLT2 in heart failure

(57:36)

Aim for Presence and Authenticity, Not Perfection | HG Dialogues with Edric and Joy Mendoza Ep. 5

(25:9)

EHJ Today - The EMPA-REG OUTCOME Trial

(11:19)

بالصوت والصورة أهم 100 محادثة فى اللغة الإنجليزية (1)

(23:15)

Cardiomyopathy Genetics: Current \u0026 Evolving Applications

(1:2:44)

EHJ Dialogue with Prof. Bernard Gersh on his journey from Zambia to Rochester

(1:2:10)

EHJ Dialogue with Prof. Karen Sliwa on cardiovascular diseases in africa

(59:1econd)

EHJ Dialogue with Prof. Anthony DeMaria on echocardiography

(1:7:56)

Study looks at best time of day to drink coffee

(4:10)

Filippo Crea and Mario Draghi - EHJ

(16:9)

EHJ Dialogue with Prof. Thomas Lüscher on the past, present and future of the EHJ

(55:16)

EHJ Dialogue with Prof. Eugene Braunwald on the 400th anniversary of cardiology

(39:31)

EHJ Dialogue with Prof. Bertram Pitt on mineralocorticoid receptor antagonists in CVD

(54:10)

EHJ Dialogue with Prof. Faiez Zannad

(1:2:21)

EHJ Dialogue with Prof. Gregory Lip on ABC Approach

(1:6:16)

EHJ Dialogue with Prof. Bernard Gersh: a journey from Zambia to Rochester USA via South Africa

(1:2:10)

EHJ Dialogue with Prof. Gregory Lip on the ABC Approach

(1:6:16)

EHJ Dialogue with Prof. Salim Yusuf on epidemiology and prevention

(52:28)

EHJ Dialogue with Prof. Göran Hanssen

(59:36)

EHJ Dialogue with Prof. Anthony DeMaria: one of the fathers of Echocardiography

(1:7:56)

EHJ Dialogue with Prof. Marc Pfeffer on PARADISE-MI

(58:41)

EHJ Dialogue with Prof. Kazem Rahimi on blood pressure reduction

(1:5:56)

EHJ Dialogue December 2022

(1:16:26)

EHJ Dialogue with Prof. George Bakris on management of diabetic chronic kidney disease

(6)

EHJ Dialogues: Prof. Christopher Cannon discussing the VERTIS trial

(47:53)